Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma.

ABSTRACT:

SUBMITTER: Trujillo JA 

PROVIDER: S-EPMC8212512 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature